Selected research
Industry Research
Breast Biopsy Site Marker Industry Research Report 2026
Market perspective
The global Breast Biopsy Site Marker market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Breast Biopsy Site Marker is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Breast Biopsy Site Marker is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Breast Biopsy Site Marker is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Breast Biopsy Site Marker include Argon Medical, BD, Carbon Medical Technologies, Hologic, INRAD, Mammotome, Mermaid Medical and Scion Medical Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Breast Biopsy Site Marker market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Breast Biopsy Site Marker Market by Company
Argon Medical
BD
Carbon Medical Technologies
Hologic
INRAD
Mammotome
Mermaid Medical
Scion Medical Technologies
Breast Biopsy Site Marker Segment by Type
Metals and Alloys
Non-Metals
Breast Biopsy Site Marker Segment by Application
Hospital
Clinic
Others
Breast Biopsy Site Marker Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breast Biopsy Site Marker market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Breast Biopsy Site Marker and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breast Biopsy Site Marker.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Breast Biopsy Site Marker manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Breast Biopsy Site Marker by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Breast Biopsy Site Marker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Metals and Alloys
- Non-Metals
Applications
- Hospital
- Clinic
- Others
Companies covered
- Argon Medical
- BD
- Carbon Medical Technologies
- Hologic
- INRAD
- Mammotome
- Mermaid Medical
- Scion Medical Technologies
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Breast Biopsy Site Marker Market Size (2021-2032)
- 2.2.2 Global Breast Biopsy Site Marker Sales (2021-2032)
- 2.2.3 Global Breast Biopsy Site Marker Market Average Price (2021-2032)
- 2.3 Breast Biopsy Site Marker by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Metals and Alloys
- 2.3.3 Non-Metals
- 2.4 Breast Biopsy Site Marker by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Breast Biopsy Site Marker Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Breast Biopsy Site Marker Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Breast Biopsy Site Marker Revenue of Manufacturers (2021-2026)
- 3.4 Global Breast Biopsy Site Marker Average Price by Manufacturers (2021-2026)
- 3.5 Global Breast Biopsy Site Marker Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Breast Biopsy Site Marker, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Breast Biopsy Site Marker, Product Type & Application
- 3.8 Global Manufacturers of Breast Biopsy Site Marker, Established Date
- 3.9 Global Breast Biopsy Site Marker Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Argon Medical
- 4.1.1 Argon Medical Company Information
- 4.1.2 Argon Medical Business Overview
- 4.1.3 Argon Medical Breast Biopsy Site Marker Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Argon Medical Breast Biopsy Site Marker Product Portfolio
- 4.1.5 Argon Medical Recent Developments
- 4.2 BD
- 4.2.1 BD Company Information
- 4.2.2 BD Business Overview
- 4.2.3 BD Breast Biopsy Site Marker Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BD Breast Biopsy Site Marker Product Portfolio
- 4.2.5 BD Recent Developments
- 4.3 Carbon Medical Technologies
- 4.3.1 Carbon Medical Technologies Company Information
- 4.3.2 Carbon Medical Technologies Business Overview
- 4.3.3 Carbon Medical Technologies Breast Biopsy Site Marker Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Carbon Medical Technologies Breast Biopsy Site Marker Product Portfolio
- 4.3.5 Carbon Medical Technologies Recent Developments
- 4.4 Hologic
- 4.4.1 Hologic Company Information
- 4.4.2 Hologic Business Overview
- 4.4.3 Hologic Breast Biopsy Site Marker Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hologic Breast Biopsy Site Marker Product Portfolio
- 4.4.5 Hologic Recent Developments
- 4.5 INRAD
- 4.5.1 INRAD Company Information
- 4.5.2 INRAD Business Overview
- 4.5.3 INRAD Breast Biopsy Site Marker Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 INRAD Breast Biopsy Site Marker Product Portfolio
- 4.5.5 INRAD Recent Developments
- 4.6 Mammotome
- 4.6.1 Mammotome Company Information
- 4.6.2 Mammotome Business Overview
- 4.6.3 Mammotome Breast Biopsy Site Marker Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mammotome Breast Biopsy Site Marker Product Portfolio
- 4.6.5 Mammotome Recent Developments
- 4.7 Mermaid Medical
- 4.7.1 Mermaid Medical Company Information
- 4.7.2 Mermaid Medical Business Overview
- 4.7.3 Mermaid Medical Breast Biopsy Site Marker Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mermaid Medical Breast Biopsy Site Marker Product Portfolio
- 4.7.5 Mermaid Medical Recent Developments
- 4.8 Scion Medical Technologies
- 4.8.1 Scion Medical Technologies Company Information
- 4.8.2 Scion Medical Technologies Business Overview
- 4.8.3 Scion Medical Technologies Breast Biopsy Site Marker Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Scion Medical Technologies Breast Biopsy Site Marker Product Portfolio
- 4.8.5 Scion Medical Technologies Recent Developments
5 Global Breast Biopsy Site Marker Market Scenario by Region
- 5.1 Global Breast Biopsy Site Marker Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Breast Biopsy Site Marker Sales by Region: 2021-2032
- 5.2.1 Global Breast Biopsy Site Marker Sales by Region: 2021-2026
- 5.2.2 Global Breast Biopsy Site Marker Sales by Region: 2027-2032
- 5.3 Global Breast Biopsy Site Marker Revenue by Region: 2021-2032
- 5.3.1 Global Breast Biopsy Site Marker Revenue by Region: 2021-2026
- 5.3.2 Global Breast Biopsy Site Marker Revenue by Region: 2027-2032
- 5.4 North America Breast Biopsy Site Marker Market Facts & Figures by Country
- 5.4.1 North America Breast Biopsy Site Marker Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Breast Biopsy Site Marker Sales by Country (2021-2032)
- 5.4.3 North America Breast Biopsy Site Marker Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Breast Biopsy Site Marker Market Facts & Figures by Country
- 5.5.1 Europe Breast Biopsy Site Marker Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Breast Biopsy Site Marker Sales by Country (2021-2032)
- 5.5.3 Europe Breast Biopsy Site Marker Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Breast Biopsy Site Marker Market Facts & Figures by Country
- 5.6.1 Asia Pacific Breast Biopsy Site Marker Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Breast Biopsy Site Marker Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Breast Biopsy Site Marker Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Breast Biopsy Site Marker Market Facts & Figures by Country
- 5.7.1 South America Breast Biopsy Site Marker Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Breast Biopsy Site Marker Sales by Country (2021-2032)
- 5.7.3 South America Breast Biopsy Site Marker Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Breast Biopsy Site Marker Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Breast Biopsy Site Marker Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Breast Biopsy Site Marker Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Breast Biopsy Site Marker Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Breast Biopsy Site Marker Sales by Type (2021-2032)
- 6.1.1 Global Breast Biopsy Site Marker Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Breast Biopsy Site Marker Sales Market Share by Type (2021-2032)
- 6.2 Global Breast Biopsy Site Marker Revenue by Type (2021-2032)
- 6.2.1 Global Breast Biopsy Site Marker Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Breast Biopsy Site Marker Revenue Market Share by Type (2021-2032)
- 6.3 Global Breast Biopsy Site Marker Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Breast Biopsy Site Marker Sales by Application (2021-2032)
- 7.1.1 Global Breast Biopsy Site Marker Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Breast Biopsy Site Marker Sales Market Share by Application (2021-2032)
- 7.2 Global Breast Biopsy Site Marker Revenue by Application (2021-2032)
- 7.2.1 Global Breast Biopsy Site Marker Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Breast Biopsy Site Marker Revenue Market Share by Application (2021-2032)
- 7.3 Global Breast Biopsy Site Marker Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Breast Biopsy Site Marker Value Chain Analysis
- 8.1.1 Breast Biopsy Site Marker Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Breast Biopsy Site Marker Production Mode & Process
- 8.2 Breast Biopsy Site Marker Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Breast Biopsy Site Marker Distributors
- 8.2.3 Breast Biopsy Site Marker Customers
9 Global Breast Biopsy Site Marker Analyzing Market Dynamics
- 9.1 Breast Biopsy Site Marker Industry Trends
- 9.2 Breast Biopsy Site Marker Industry Drivers
- 9.3 Breast Biopsy Site Marker Industry Opportunities and Challenges
- 9.4 Breast Biopsy Site Marker Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst